Interesting to note that in the top 40's;RRS - approaching 60% of holders in top 40RRSO - nearly 80% of holders in top 40Company management and board members feature prominantly in the top ten of eachVery tightly heldjr
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%